News
Prostate cancer is the most common cancer diagnosis in men in the United States and a leading cause of cancer-related morbidity and mortality (1). It can exist along a wide spectrum of aggressiveness ...
Radiopharmaceuticals Good manufacturing practice–grade PSMA-11 and PSMA-617 were obtained from ABX. 225 Ac was produced by radiochemical extraction from 229 Th (9,10). 68 Ga was eluted from a 68 Ge/ ...
The clinical presentations of early idiopathic Parkinson disease (IPD) substantially overlap with those of atypical parkinsonian syndromes such as multiple system atrophy (MSA) and progressive ...
Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177 Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine MIRD Pamphlet No. 28, Part ...
The development of artificial intelligence (AI) within nuclear imaging involves several ethically fraught components at different stages of the machine learning pipeline, including during data ...
Multiple myeloma (MM) is a hematologic neoplasm characterized by the clonal proliferation of malignant plasma cells in the bone marrow. It is almost always preceded by an initial monoclonal gammopathy ...
Heart failure (HF) is a major cause of morbidity and mortality in the United States and worldwide. The total prevalence of HF is projected to increase by almost 50% from 2012 to 2030, affecting more ...
Dr. Richard Zimmermann is a distinguished figure in the field of nuclear medicine and radiopharmaceuticals. With a strong academic foundation, he holds MSc degrees in organic chemistry, physical ...
Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated promising applications of LLMs in medical imaging, and this number will grow as ...
Antiamyloid therapies for Alzheimer disease recently entered clinical practice, making imaging biomarkers for Alzheimer disease even more relevant to guiding patient management. Amyloid and tau PET ...
Journal of Nuclear Medicine February 2025, jnumed.124.268967; DOI: https://doi.org/10.2967/jnumed.124.268967 Cancer therapy has advanced with molecularly targeted ...
The use of brain PET in research has spanned more than 5 decades. PET has been shown to be a valuable tool for assessing changes in flow, metabolism, and receptor occupancy resulting from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results